Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New LC Column Line for Protein Separations

Published: Monday, January 28, 2013
Last Updated: Monday, January 28, 2013
Bookmark and Share
Company introduces Amplus® wide-pore core shell HPLC columns at ASMS Sanibel Conference.

Protea Biosciences Group, Inc. has announced at the ASMS Sanibel Conference the introduction of Amplus® wide-pore core shell HPLC columns, a new line of liquid chromatography columns specifically designed for intact proteins analysis.

This new family of HPLC silica-based columns employ core shell technology combined with a specific porosity designed to facilitate proteins separation, including those with high molecular weight.

“This year the ASMS Sanibel Conference is focused on Top Down proteomics applications and we thought it was a great opportunity to introduce a new technology designed for intact protein chromatographic analysis,” stated Alessandro Baldi, PhD, Vice President and General Manager of Protea Biosciences.

Baldi continued, ‘Amplus’ technology provides scientists with high chromatographic efficiency and facilitates Top Down proteomics approach to study intact proteins with or without mass spectrometry.”

Amplus, the new brand of analytical columns, has been developed in collaboration with the Japanese firm CromaNik Technologies and it is available in different chemistries and porosities to facilitate and resolve the most difficult separations in Top Down proteomics studies.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Protea Announces Agreement to Acquire vivoPharm
Combined Company to develop and market new services for pharmaceutical R&D.
Thursday, April 09, 2015
Protea to Acquire vivoPharm
Combined company to develop and market new services for pharmaceutical R&D.
Wednesday, April 08, 2015
National Institute For Occupational Safety And Health Partners With Protea
NIOSH utilizes mass spectrometry imaging tools for workplace toxin inhalation studies.
Friday, March 20, 2015
Protea, MSK, Dana-Farber Enter Collaborative Research Agreement
Protea's LAESI technology to be used to profile cancer cells to improve diagnosis and treatment selection
Wednesday, April 30, 2014
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!